Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 44.26 EUR 0.73% Market Closed
Market Cap: 26B EUR
Have any thoughts about
Fresenius Medical Care AG?
Write Note

Fresenius Medical Care AG
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fresenius Medical Care AG
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Fresenius Medical Care AG
XMUN:FME
Non-Reccuring Items
€1.7m
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
11%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Non-Reccuring Items
€1.7m
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
11%
Fresenius SE & Co KGaA
XETRA:FRE
Non-Reccuring Items
-€45m
CAGR 3-Years
-36%
CAGR 5-Years
-86%
CAGR 10-Years
N/A
Vita 34 AG
XETRA:V3V
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Euroeyes International Eye Clinic Ltd
HKEX:1846
Non-Reccuring Items
-HK$382k
CAGR 3-Years
N/A
CAGR 5-Years
49%
CAGR 10-Years
N/A
Synlab AG
XETRA:SYAB
Non-Reccuring Items
-€45.6m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Fresenius Medical Care AG
Glance View

Market Cap
26B EUR
Industry
Health Care

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
52.54 EUR
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Fresenius Medical Care AG's Non-Reccuring Items?
Non-Reccuring Items
1.7m EUR

Based on the financial report for Jun 30, 2024, Fresenius Medical Care AG's Non-Reccuring Items amounts to 1.7m EUR.

What is Fresenius Medical Care AG's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
11%

Over the last year, the Non-Reccuring Items growth was -98%.

Back to Top